SAVA - Cassava Sciences, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.46 0.17 (3.79%)	0.0 (0.0%)	0.0 (0.0%)	0.07 (1.5%)	0.03 (0.67%)	0.15 (3.33%)	-0.02 (-0.45%)	-0.02 (-0.45%)

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.92
Diluted EPS:: -0.92
Basic P/E:: -5.0317
Diluted P/E:: -5.0317
RSI(14) 1m:: 0.0
VWAP:: 4.63
RVol:: 0.7146

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	4.51 -0.09 (-1.93%)	Oct 15 17:46
1m	Price decrease 1m	4.52 -0.05 (-1.1%)	Oct 15 12:29
10m	Price increase 10m	4.63 +0.14 (+3.17%)	Oct 15 10:49
60m	Price increase 60m	4.59 +0.22 (+5.04%)	Oct 15 10:48
1m	Price increase 1m	4.52 +0.04 (+1.01%)	Oct 15 10:42